Literature DB >> 8395439

Molecular classification of hepatitis C virus.

M Mizokami1, K Ohba.   

Abstract

Many sequences of hepatitis C virus (HCV) have been reported, but there has been no report about the evolutionary classification of HCV. The aim of this study is to classify the nucleotide sequences of HCV into appropriate genetical groups by molecular evolutionary methods. A number of nucleotide sequences of HCV were collected from all over the world. First, all HCV nucleotide sequences for each region were aligned to optimize homologies. Phylogenetic trees were then constructed for each region of HCV according to the number of the nucleotide substitutions. HCVs can be classified into two or three major groups in the trees of each regions. However, minor groups can be classified into two in that of 5' non-coding, four in that of Core, Env., E2/NS1, NS3 and NS4 region and six in that of NS5 region. However, the full sequences such as HCV-1, HCVH and HCV-J4, were always located in the same major and minor groups in that trees of all regions. These data indicated that HCVs can be classified into two or three major and six minor groups.

Entities:  

Mesh:

Year:  1993        PMID: 8395439     DOI: 10.1007/bf02989203

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  4 in total

1.  A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.

Authors:  A Y Howe; R Chase; S S Taremi; C Risano; B Beyer; B Malcolm; J Y Lau
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

2.  Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patients.

Authors:  T Ohno; M Mizokami; M G Saleh; E Orito; K I Ohba; R R Wu; T Koide; C J Tibbs; K T Nouri-Aria; S Tokudome; R Williams
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus.

Authors:  T Ohno; M Mizokami; M Yamauchi; K Ohba; E Orito; R R Wu; M Mizuno; K Sugihara; T Wakita; S Kakumu
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

4.  Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Anita Y M Howe; Johnathan Bloom; Carl J Baldick; Christopher A Benetatos; Huiming Cheng; Joel S Christensen; Srinivas K Chunduru; Glen A Coburn; Boris Feld; Ariamala Gopalsamy; William P Gorczyca; Steve Herrmann; Stephen Johann; Xiaoqun Jiang; Michelle L Kimberland; Girija Krisnamurthy; Matthew Olson; Mark Orlowski; Steve Swanberg; Ian Thompson; Megan Thorn; Alfred Del Vecchio; Dorothy C Young; Marja van Zeijl; John W Ellingboe; Janis Upeslacis; Marc Collett; Tarek S Mansour; John F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.